S. 4469 · 118th Congress · Health

Chronic Kidney Disease Improvement in Research and Treatment Act of 2024

Died in committee2.4k words Introduced Jun 5, 2024 · Latest action Jun 5, 2024

How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedJun 5, 2024 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. Senate floorNot yet Not reached yet
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

3 organizations · 9 filings · Q2 2024–Q4 2024

See which of this bill’s sponsors and cosponsors got money from the lobbying organizations’ PACs → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Fresenius Medical Care North America 3 of 3 quarters
    “Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860/S. 5018, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 10545, American Relief Act…”

    $6.5M lobbying spend in 2024, all issuesQ4 2024 filing

  2. Davita Inc 3 of 3 quarters
    “…S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act”

    $4.2M lobbying spend in 2024, all issuesQ4 2024 filing

  3. Akebia Therapeutics, Inc. 3 of 3 quarters
    “H.R. 4366, Consolidated Appropriations Act of 2024, including provisions relating to health care H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 6860, Restore Protections for Dialysis Patients Act H.R. 7085, BIOSECURE Act S. 3558, to prohibit contracting with certain…”

    $1.1M lobbying spend in 2024, all issuesQ4 2024 filing

Organizations that named S. 4469 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Jun 5, 2024Read twice and referred to the Committee on Finance.
  2. Jun 5, 2024Introduced in Senate